InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Travere Therapeutics, Inc.

TVTX Clue Score50
United States Fiscal year ends December CIK 0001438533 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Christopher R. Cline
2 Sep 2026
Chief Financial Officer
Sell
642
$66.37
$42.61K
Peter Heerma
5 May 2026
Chief Commercial Officer
Sell
2,174
$46.65
$101.42K
Peter Heerma
14 Apr 2026
Chief Commercial Officer
Sell
7,215
$41.93
$302.52K
Elizabeth E Reed
3 Feb 2026
Chief Legal Officer and GC
Sell
7,175
$32.12
$230.46K
Sandra Calvin
3 Feb 2026
SVP, Chief Accounting Officer
Sell
4,333
$32.12
$139.18K
Peter Heerma
3 Feb 2026
Chief Commercial Officer
Sell
7,310
$32.12
$234.80K
Christopher R. Cline
3 Feb 2026
Chief Financial Officer
Sell
7,242
$32.12
$232.61K
Jula Inrig
3 Feb 2026
Chief Medical Officer
Sell
6,956
$32.12
$223.43K
Show all 118 transactions →

What was left out

Form 4 filings counted 69
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 75
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 2,184,722
History held since 26 Dec 2012